BridgeBio Pharma, Inc. (BIT:1BBIO)

BridgeBio Pharma Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 2, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Cap	10,789	12,816	4,486	6,080	987	2,114
Market Cap Growth	71.82%	185.69%	-26.22%	515.81%	-53.30%	-71.87%
Enterprise Value	11,897	13,922	5,398	7,199	2,040	2,883
PE Ratio	-	-20.24	-9.53	-10.22	-2.34	-4.28
PS Ratio	25.23	29.67	23.50	759.77	14.78	35.25
PB Ratio	-6.10	-7.14	-3.55	-5.22	-0.91	-2.82
P/TBV Ratio	-5.07	-7.02	-3.48	-4.85	-0.90	-2.77
P/FCF Ratio	-	-33.33	-10.00	-13.36	-2.70	-4.81
P/OCF Ratio	-	-33.41	-10.01	-13.39	-2.74	-4.94
EV/Sales Ratio	27.48	32.23	28.28	899.51	30.54	48.08
EV/EBITDA Ratio	-	-31.24	-10.69	-13.93	-4.69	-5.87
EV/EBIT Ratio	-	-30.92	-10.58	-13.78	-4.63	-5.81
EV/FCF Ratio	-31.25	-36.20	-12.03	-15.82	-5.59	-6.56
Debt / Equity Ratio	-0.90	-0.90	-1.19	-1.30	-1.38	-1.99
Debt / EBITDA Ratio	-3.60	-3.60	-2.95	-2.90	-3.41	-3.02
Debt / FCF Ratio	-4.17	-4.17	-3.32	-3.29	-4.06	-3.38
Net Debt / Equity Ratio	-0.61	-0.61	-0.71	-0.95	-0.97	-1.02
Net Debt / EBITDA Ratio	-2.46	-2.46	-1.79	-2.14	-2.40	-1.56
Net Debt / FCF Ratio	-2.85	-2.85	-2.01	-2.43	-2.86	-1.74
Asset Turnover	0.54	0.54	0.30	0.02	0.09	0.08
Inventory Turnover	1.57	1.57	-	-	-	-
Quick Ratio	2.52	2.52	4.44	3.15	4.34	6.34
Current Ratio	2.77	2.77	4.67	3.32	4.52	6.58
Return on Equity (ROE)	41.48%	41.48%	38.81%	50.49%	45.93%	154.80%
Return on Assets (ROA)	-56.45%	-56.45%	-81.08%	-103.88%	-62.62%	-67.19%
Return on Invested Capital (ROIC)	-317.22%	-317.22%	-893.11%	-4398.04%	-902.91%	-1016.39%
Return on Capital Employed (ROCE)	-74.09%	-74.09%	-101.58%	-134.35%	-74.27%	-77.63%
Earnings Yield	-5.72%	-4.94%	-10.50%	-9.78%	-42.78%	-23.38%
FCF Yield	-3.53%	-3.00%	-10.00%	-7.48%	-36.97%	-20.80%
Buyback Yield / Dilution	0.19%	0.19%	-6.05%	-6.40%	-0.57%	7.50%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.